Practice
Short cuts
US guidelines on epoetin alfa tainted by links with industry
BMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7579.1164-a (Published 30 November 2006) Cite this as: BMJ 2006;333:1164
Nephrologists and patients with chronic renal failure urgently need independent guidance on the safest way to treat anaemia with epoetin alfa, writes a commentator from the US, where the guideline developer, the National Kidney Foundation, is mired in …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.